Butterfly Network

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Butterfly Network reports Q4 growth, seeks CEO for tech scaling

Butterfly Network's Q4 2022 performance showed revenue growth and improved cost management.
The company's strengths lie in democratizing healthcare, international expansion, and cost efficiency.
Challenges include external factors affecting deployments and the ongoing CEO search.
Opportunities for growth include revenue expectations, product developments, and efficiency enhancements.

Butterfly Network reports stable Q1 revenue, eyes AI and home markets

Butterfly Network's Q1 2023 performance showed mixed results with flat revenue but improved margins and reduced EBITDA loss.
The company's strengths in democratizing medical imaging, AI utilization, and strong cash position position it well for future growth.
Challenges include product revenue decline, slower customer growth, and the need to address international distribution weaknesses.
Opportunities in AI, software expansion, home market penetration, and exciting developments offer avenues for future success.

Butterfly Network reports Q2 revenue, focuses on innovation and growth

Butterfly Network's Q2 2023 performance showed mixed results with growth in U.S. sales but a decline in international sales.
The company is leveraging core strengths, launching innovative products, and focusing on revenue growth initiatives.
Challenges include declining international sales and potential impact on current sales due to the upcoming iQ3 launch.
Opportunities lie in new product launches, e-commerce strategy, market expansion, and technology advancements beyond iQ3.

Butterfly Network reports Q3 revenue decline but eyes future growth

Butterfly Network's Q3 2023 performance reflects a strategic shift towards higher-margin offerings and improved operational efficiency.
The company's strengths in revolutionizing ultrasound imaging, education offerings, and partnerships position it for future growth.
Challenges include revenue decline, competitive landscape, and the need for sustained investment in R&D and operational improvements.
Opportunities in upcoming product launches, market expansion, and revenue-sharing agreements present avenues for growth and innovation.

Butterfly Network reports improved Q4 financials and plans expansion

Butterfly Network's financials improved in Q4 2023 with revenue decline but better margins.
Strategic focus on product innovation, global expansion, and revenue growth drivers.
Challenges include revenue decline, EBITDA loss, and potential regulatory impacts.
Opportunities lie in planned growth strategies, resource additions, and lobbying efforts.

Butterfly Network excels in Q1 2024, eyes global expansion

Butterfly Network's Q1 2024 showcased strong revenue growth and operational improvements.
While facing challenges with compliance and financial losses, the company is optimistic about growth.
Strategic priorities and innovative technologies position Butterfly for future success and market expansion.

Butterfly Network reports robust Q2 growth, eyes AI opportunities

Butterfly Network's Q2 performance reflects strong revenue growth, improved cost efficiency, and a positive outlook for the year. The company's strengths in sustainable revenue growth, AI advancements, and strategic partnerships enhance its competitive position. Challenges in regulatory compliance and market expansion require careful navigation, while opportunities in AI, partnerships, and clinical applications offer avenues for growth.

Butterfly Network posts robust Q3 results, eyes tech innovation for growth

Butterfly Network's Q3 2024 performance reflects strong revenue growth, improved profitability, and strategic initiatives for future expansion and innovation.
While facing challenges in managing EBITDA losses and regulatory compliance, the company's financial strength and growth outlook present a positive trajectory.
Opportunities in technological innovation, market expansion, and healthcare initiatives position Butterfly Network for sustained growth and competitive advantage in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the 43rd Annual J.P. Morgan Healthcare Conference taking place January 13-16, 2025 at the Westin St. Francis in San Francisco, California. Joseph DeVivo, President, Chief Executive Officer & Chairman and Heather Getz, Executive Vice President &.

Butterfly Network to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Here is how Butterfly Network, Inc. (BFLY) and argenex SE (ARGX) have performed compared to their sector so far this year.

Is Butterfly Network (BFLY) Stock Outpacing Its Medical Peers This Year?

Clover Health Investments

Inspire Medical Systems Inc

Omnicell

Talkspace

Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

CONMED

Madrigal Pharmaceuticals

As of Nov. 25, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Health Care Stocks That May Dip This Month

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that its management will present and host one-on-one meetings at the virtual BTIG Digital Health Forum on November 25, 2024. Presentations at the event will include: 9:00 am ET Fireside Chat: Joseph DeVivo, President, Chief Executive Officer and Chairman, and Heather Getz, Executi.

Butterfly Network to Participate at the Virtual BTIG Digital Health Forum on November 25, 2024

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Butterfly iQ3™, its third-generation handheld ultrasound device, was the recipient of the Best Medical Technology Award at the 2024 Prix Galien USA Awards by the Galien Foundation. The Galien Foundation was established to foster and reward.

Butterfly Network's iQ3™ Honored as the Best Medical Technology at 2024 Prix Galien USA Awards

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation at the Canaccord Genuity (CG) MedTech, Diagnostics and Digital Health & Services Forum in New York City on November 21, 2024. Joseph DeVivo, President, Chief Executive Officer & Chairman, and Heather Getz, Executive Vice President & Chief Financial an.

Butterfly Network to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024

Butterfly Network, Inc. (NYSE:BFLY ) Q3 2024 Earnings Conference Call November 1, 2024 8:00 AM ET Company Participants Heather Getz – Chief Financial and Operations Officer Joseph DeVivo – Chairman and Chief Executive Officer Conference Call Participants Suraj Kalia – Oppenheimer Josh Jennings – TD Cowen Ben Haynor – Lake Street Capital Markets Operator Hello, everyone, and welcome to the Butterfly Network Q3 2024 Earnings Call. My name is Carla, and I will be coordinating your call today.

Butterfly Network, Inc. (BFLY) Q3 2024 Earnings Call Transcript

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.13 per share a year ago.

Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Tops Revenue Estimates

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the third quarter ended September 30, 2024, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “The Butterfly team is proud to report a fifth consecutive.

Butterfly Network Reports Third Quarter 2024 Financial Results

BORDEAUX, France--(BUSINESS WIRE)--HeartFocus, the revolutionary, AI-enabled heart echo software by data-driven medtech company, DESKi, is proud to announce the launch of the HeartFocus Education app in partnership with Butterfly Network, Inc., (“Butterfly”) (NYSE: BFLY) a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software. The innovative HeartFocus Education app is designed to elevate any healthcare practitioner to mastering.

HeartFocus Unveils AI-powered Education App for Conducting Clinical-Grade Heart Scans, Available on Butterfly Network's Handheld Ultrasound Devices

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report third quarter 2024 financial results on November 1, 2024 at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and Heather Getz, Executive Vice President and Chief Financial and Operations Officer, will host.

Butterfly Network to Report Third Quarter 2024 Financial Results on November 1, 2024

KCU incorporates Butterfly Network's AI-guided ScanLab™ education application into its curriculum to empower dedicated, hands-on ultrasound training. KANSAS CITY, Mo.

Kansas City University Sets New Standard in Point-of-Care Ultrasound Education with AI-Guided Training Curriculum

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today published a case study highlighting the positive impact of University of Rochester Medical Center's (URMC) transformative, system-wide deployment of Butterfly's point-of-care ultrasound (POCUS) devices and enterprise ultrasound platform, C.

University of Rochester Medical Center Boosts Diagnostic Accuracy and Workflow Efficiency with Butterfly Network's Enterprise Ultrasound Solution

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”) (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Fierce Life Sciences and Fierce Healthcare have named Butterfly as one of 2024's Fierce 50 honorees. The Fierce 50 showcases 50 individuals and companies driving advancements in medicine, fostering innovation, and shaping the future of biop.

Fierce Names Butterfly Network as a Fierce 50 Honoree of 2024

Here is how Butterfly Network, Inc. (BFLY) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?

Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.

Butterfly Network's Stock Surges on iQ3 Device Launch in Europe

Bill.com

As the month of September begins on a bearish note for the majority of assets in the stock market, investors are looking at shares to add to their portfolios that might offer potential for profit, and sometimes insider trading activity for certain stocks can help them decide.

2 stocks popular among insider traders

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network Inc. (“Butterfly,” “the Company”) (NYSE: BFLY), a digital health company transforming care with portable semiconductor-based ultrasound technology and intuitive software, announced the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3™ in Europe. Butterfly iQ3 is powered by the Company's most advanced semiconductor chip, enabling unparalleled image quality and new advanced 3D.

Butterfly Network Expands its Next-Generation Butterfly iQ3™ to Europe

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation in Lake Street Capital Markets' 8th Annual Best Ideas Growth Conference, taking place in New York City on September 12, 2024. Heather Getz, Chief Financial and Operations Officer at Butterfly Network, will represent Butterfly in one-on-one investor meetings at t.

Butterfly Network to Participate in Lake Street Capital Markets' 8th Annual Best Ideas Growth Conference "Big 8"

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company's successful launch of its third-generation Butterfly iQ3 and historic revenue performance in the first half of 2024. Cashman.

Butterfly Network Appoints Steve Cashman as Chief Business Officer

The Dow Jones index closed higher by more than 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.

Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively Buying

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its participation in TD Cowen's 9th Annual FutureHealth Conference, taking place in New York City on September 10, 2024. Nevada Sanchez, Co-Founder & Vice President of Core Technology at Butterfly Network, will participate in a panel discussion titled "AI in the Healthcare Ec.

Butterfly Network to Participate in TD Cowen's 9th Annual FutureHealth Conference

Butterfly Network, Inc. (NYSE:BFLY ) Q2 2024 Earnings Conference Call August 1, 2024 5:00 PM ET Company Participants Heather Getz - Chief Financial and Operations Officer Joseph DeVivo - Chairman and CEO Conference Call Participants Josh Jennings - TD Cowen Suraj Kalia - Oppenheimer & Co. Operator Good evening. Thank you for attending the Butterfly Network Second Quarter 2024 Earnings Call.

Butterfly Network, Inc. (BFLY) Q2 2024 Earnings Call Transcript

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.14 per share a year ago.

News for Butterfly Network Stock (BFLY)